Filing Details

CUSIP No. 92023M101

13G

Page 2 of 5   Pages

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Dov Malnik

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐

(b)  ☐

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Israel

 

NUMBER OF
SHARES
BENEFICIALLY

OWNED

BY
EACH
REPORTING
PERSON

WITH

5

SOLE VOTING POWER

 

509,781

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

509,781

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

509,781

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                      ☐

 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

7.5 %

12

TYPE OF REPORTING PERSON*

 

IN

Item 1(a)

Name of Issuer:

Vallon Pharmaceuticals, Inc. (the “Issuer”)

Item 1(b)

Address of Issuer's Principal Executive Offices:

100 N. 18^th Street, Suite 300,

Philadelphia, PA 19103

Item 2(a)

Name of Person Filing:

The information required by Item 2(a) is set forth in Row 1 of the cover page hereto and is incorporated herein by reference.

Item 2(b)

Address of Principal Business Office or, if none, Residence:

8 Shlinka St.

Rishon le zion, 75451, Israel

Item 2(c)

Citizenship:

The information required by Item 2(c) is set forth in Row 4 of the cover page hereto and is incorporated herein by reference.

Item 2(d)

Title of Class of Securities:

Common Stock, $0.0001 par value per share (“Common Stock”)

Item 2(e)

CUSIP Number:

92023M101

Item 3

Statement filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c):

The information required by Item 3 is set forth in Row 12 of the cover page hereto and is incorporated herein by reference.

Item 4

Ownership:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page hereto and is incorporated herein by reference.

The ownership percentage disclosed in Row 11 of the cover page hereto is based on 6,812,836 outstanding shares of Common Stock, as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 12, 2021.

Item 5

Ownership of Five Percent or Less of a Class:

Not Applicable

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

Not Applicable

Item 8

Identification and Classification of Members of the Group:

Not Applicable

Item 9

Notice of Dissolution of Group:

Not Applicable

Item 10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

REPORTING PERSON

Name:  Dov Malnik